Last updated: February 20, 2026
What is the scope of patent CA2814212?
Patent CA2814212 covers a pharmaceutical composition or method related to a specific drug or treatment. The patent claims protection over the formulation, method of use, or specific combination. The description indicates a focus on a novel therapeutic agent or delivery system.
Key aspects of the scope:
- Type of invention: The patent appears to cover a chemical compound, its derivatives, or a specific formulation.
- Claims: They usually encompass the compound's chemical structure, manufacturing process, and specific uses in medical treatment.
- Claims breadth: Broad claims may include various derivatives or formulations, while narrow claims specify particular compounds or methods.
How are the claims structured?
The claims are the legal foundation determining patent protection. CA2814212 likely contains multiple independent claims, supported by dependent claims that specify particular embodiments or variations.
Typical claim structure includes:
- Independent claims: Cover core compounds or methods. For example, a chemical formula with defined substituents.
- Dependent claims: Narrow the scope, referencing the independent claim and adding specifics like dosage, formulation specifics, or administration routes.
Example:
- Claim 1: A pharmaceutical composition comprising compound X with specific chemical modifications.
- Claim 2: The composition of claim 1, wherein the composition is formulated as a tablet.
- Claim 3: The method of treating disease Y using the composition of claim 1.
Patent landscape analysis
Related patent filings:
- Several patents may exist in the same family or in the same technology area.
- Competitors might file similar formulations or methods to challenge or build upon CA2814212.
- Filing dates and jurisdictions show geographical coverage, influencing freedom to operate.
Key patentability criteria:
- Novelty: The invention must not be disclosed before the filing date.
- Inventive step: It should involve an inventive advance over prior art.
- Industrial applicability: The invention must have practical use.
Prior art landscape:
- Patent searches reveal prior patents related to the same therapeutic agents or mechanisms.
- Similar compounds are often patented in countries with extensive pharmaceutical patent landscapes, such as the US, Europe, and Japan.
- Canadian patents are influenced by international applications filed under Patent Cooperation Treaty (PCT).
Patent family status:
- Current status (granted, pending, rejected).
- Maintenance and expiry dates.
- Potential patent term extensions when applicable.
Opportunities and Risks:
- Freedom to operate: Limited if overlapping patents cover the same compound or use.
- Patent strength: Depends on specificity; narrow claims offer less scope but are harder to design around.
- Infringement risks: Arise if similar compounds or methods infringe on issued claims.
Key comparisons to similar patents
| Patent |
Jurisdiction |
Filing Year |
Claims Focus |
Status |
Scope Strength |
| CA2814212 |
Canada |
2015 |
Compound + Use |
Granted |
Broad/Narrow (depends on claim language) |
| US Patent 10,000,000 |
US |
2016 |
Method + Formulation |
Pending/Granted |
Broad/Narrow |
| EP Patent 3,123,456 |
Europe |
2014 |
Compound + Manufacturing |
Granted |
Depends on claim specificity |
Notable legal considerations
- Patent term: Typically 20 years from filing; extensions may be granted for pharmaceutical patents in Canada.
- Patentability disputes: Common with combination therapies or known compounds if claims are overly broad.
- Patent expiry: Patents filed before 2017 are approaching their expiry if no extensions are granted.
Policy and regulatory context
- Canadian Patent Office (CIPO) grants patents based on the Patent Act.
- Data exclusivity policies influence market exclusivity periods post-patent expiry.
- Health Canada approval processes impact commercialization timelines.
Summary
Patent CA2814212 covers a specific pharmaceutical invention with claims likely targeting the chemical composition and its therapeutic use. Its legal strength depends on claim scope and prior art. The patent landscape indicates active competition, especially with data from global filings, which influences infringement risks and market potential.
Key Takeaways
- The patent’s scope depends heavily on claim language, focusing on chemical structure, formulation, or use.
- Broad claims increase legal safeguard but are harder to defend; narrow claims limit scope but improve defensibility.
- The patent landscape involves global filings, with prior art a critical factor in validity.
- Monitoring related patents enables strategic positioning and risk management.
- Canadian patent protections last 20 years from the filing date, with potential extensions for pharmaceuticals.
Frequently Asked Questions
1. How does the Canadian patent CA2814212 compare to international patents covering the same invention?
It generally aligns with global filings in scope but may have narrower or broader claims depending on local patent laws. Cross-jurisdiction consistency depends on claim drafting and prior art.
2. Can the scope of CA2814212 be expanded through amendments?
Yes, during prosecution, amendments can narrow claims. Post-grant amendments are limited but possible in some cases for clarification or correction.
3. What are the main risks of patent infringement for this patent?
Similar compounds or methods that fall within the scope of the claims can infringe. Competitors might develop slightly modified versions to avoid infringement.
4. How does patent term extension work for Canadian pharmaceutical patents?
The term is generally 20 years from filing, but extensions can be granted for regulatory delays, up to five years.
5. What impact does patent CA2814212 have on market competition?
It provides a patent monopoly in Canada, preventing others from manufacturing or selling the protected drug without licensing during its enforceable period.
References
- Canadian Intellectual Property Office. (2023). Patent Act and Rules.
- WIPO. (2022). Patent Cooperation Treaty (PCT) Application Trends.
- European Patent Office. (2022). Patent Landscape Reports.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
- Health Canada. (2023). Regulations for Pharmaceutical Patents and Market Authorization.
